Does insulin resistance predict prostate cancer? Results from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial
In summary, higher HOMA-IR was associated with a reduced risk of low-grade PC but was not associated with high-grade disease. The mechanisms to explain these findings are unclear.
Authors
- Alexis R. Freedland (ORCID: https://orcid.org/0000-0001-5277-5113)
- James P. Daniels (ORCID: https://orcid.org/0000-0002-2401-2474)
- Shakiba Eslamimehr
- Daniel M. Moreira (ORCID: https://orcid.org/0000-0003-4517-244X)
- Stephen J. Freedland (ORCID: https://orcid.org/0000-0002-8104-6419)
- Lourdes Guerrios‐Rivera (ORCID: https://orcid.org/0000-0003-3846-5105)
- Jay H. Fowke (ORCID: https://orcid.org/0000-0003-3803-8162)
- Renning Zheng
Institutions
- Cedars-Sinai Medical Center (US)
- University of Louisville (US)
- University of Puerto Rico, Medical Sciences Campus (PR)
- University of Tennessee Health Science Center (US)
- Illinois College (US)
- University of California, Irvine (US)
- University of Illinois Chicago (US)
- Durham VA Health Care System (US)
- Tsinghua University (CN)
Publication Details
- Journal
- Cancer
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1002/cncr.35568
- Citations
- 4
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- National Institutes of Health